City of Hope is a world leader in the research and treatment of cancer, diabetes, and other serious diseases. It has been ranked as one of the nation’s “Best Hospitals” in cancer by U.S. News & World Report for over 10 years.
In 2017, the Simms/Mann Family Foundation partnered with City of Hope to establish the Simms/Mann Family Foundation Chair in Systems Biology, naming Jianjun Chen, Ph.D. as chair. Dr. Chen is a leader in the use of systems biology to address disparities in therapeutic options for acute leukemia. Preclinical investigations have shown great promise for better therapeutic options. At City of Hope, Dr. Chen hopes to translate these early successes into clinical trials. By establishing the Simms /Mann Family Foundation Chair, the Foundation hopes to provide Dr. Chen with the tools to translate promising research into tangible therapies and to allow Dr. Chen, and the brilliant researchers who follow in his footsteps, to redefine the way the world understands and treats acute leukemia and other cancers.
People around the world who are fighting cancer find hope in the promise of experimental new therapies that may lead to a cure for themselves and future generations. By empowering Dr. Chen to pursue his transformative research, the Simms/Mann Family Foundation’s support helps City of Hope continue to push the boundaries of science, advancing treatments that extend quality and length of life and cultivating hope for people with cancer.